Search PubMed⌕ Search

PubMed · 11488872

Rapid screening: a comparative study.

Abstract

Although rapid screening of negative and inadequate cervical smears is a quality assurance requirement for all UK laboratories, there has been little attempt to standardize the method and laboratories make use of a number of different techniques and times. The aim of this study was to assess the sensitivity of these various techniques by measuring their ability to pick out known false-negative smears. Completed questionnaires from 123 laboratories across England revealed that 52% of laboratories use a "step" technique, 19% use "turret", 15% use random paths and 34% attempt to rescreen the whole slide quickly. Twenty-two percent of laboratories use a mixture of techniques. Timings are also variable, with the majority of laboratories allowing screeners to review slides at a pace decided by themselves but usually between 1 and 2 min. The study involved 120 participants who performed a total of 24 000 rapid screens. The results showed that, of the 90 abnormal slides used in the study, 62 cases (69%) were identified as abnormal or needing review by more than 50% of participants. Overall rapid screening picked out 58% of high-grade squamous abnormalities, 59% of low-grade abnormalities and 72% of glandular lesions. Step screening performed best, followed by whole slide/random and then turret. One minute was the optimum time and there was a significant fall in performance once individuals attempted to rescreen large numbers (>50). The most significant finding was the marked variation in the performance of individuals using the same slide sets.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

N Dudding, E M Hewer, L Lancucki, S Rice. 2001. Rapid screening: a comparative study.. https://doi.org/10.1046/j.1365-2303.2001.00340.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Doctors are increasingly held liable for missed diagnosis of cancer in mass screening].

Radiologists and pathologists are increasingly subjected to litigation for alleged faults in diagnosing cancer. An important cause of this appears to be the introduction of mass screening for cancer. According to liability law, the judge must assess whether the person making the diagnosis effected his/her duty with due care. The distinction between error and incompetence cannot be judged solely on the basis of the individual case, but requires an estimation of the accuracy of the diagnosis on a population level. The traditional role of the expert witness, who is asked to judge the individual cases, needs to be reconsidered. A re-examination of slides or radiograms with prior knowledge of the outcome obtained does no justice to the original situation and an alternative procedure is therefore needed. Since the government initiates and controls population screening and the professional organisations involved in screening have committed themselves to monitoring the process and the results obtained, the general public must be better informed about the limitations of screening. Unrealistic expectations as to the benefits of screening appear to be an important motive for legal actions. It is questionable whether screening quality can be enhanced by means of the preventive effect of professional liability. Doctors and lawyers should analyse and solve this problem together.

Diagnostic Errors↗